Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 6.29
ATEC's Cash-to-Debt is ranked lower than
65% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. ATEC: 6.29 )
Ranked among companies with meaningful Cash-to-Debt only.
ATEC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.64 Max: N/A
Current: 6.29
Equity-to-Asset -0.45
ATEC's Equity-to-Asset is ranked lower than
96% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. ATEC: -0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
ATEC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.45  Med: 0.56 Max: 0.72
Current: -0.45
-0.45
0.72
Piotroski F-Score: 5
Altman Z-Score: -4.66
Beneish M-Score: -4.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -11.60
ATEC's Operating Margin % is ranked lower than
65% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. ATEC: -11.60 )
Ranked among companies with meaningful Operating Margin % only.
ATEC' s Operating Margin % Range Over the Past 10 Years
Min: -93.07  Med: -18.5 Max: 0.89
Current: -11.6
-93.07
0.89
Net Margin % -21.30
ATEC's Net Margin % is ranked lower than
72% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.14 vs. ATEC: -21.30 )
Ranked among companies with meaningful Net Margin % only.
ATEC' s Net Margin % Range Over the Past 10 Years
Min: -96.44  Med: -18.23 Max: -6.22
Current: -21.3
-96.44
-6.22
ROA % -24.50
ATEC's ROA % is ranked lower than
76% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. ATEC: -24.50 )
Ranked among companies with meaningful ROA % only.
ATEC' s ROA % Range Over the Past 10 Years
Min: -72.69  Med: -11.49 Max: -3.63
Current: -24.5
-72.69
-3.63
ROC (Joel Greenblatt) % -31.40
ATEC's ROC (Joel Greenblatt) % is ranked lower than
62% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.86 vs. ATEC: -31.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ATEC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -252.2  Med: -47.38 Max: 3.33
Current: -31.4
-252.2
3.33
3-Year Revenue Growth Rate -5.10
ATEC's 3-Year Revenue Growth Rate is ranked lower than
76% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. ATEC: -5.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ATEC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -5.1  Med: -0.15 Max: 32.4
Current: -5.1
-5.1
32.4
3-Year EPS without NRI Growth Rate 119.20
ATEC's 3-Year EPS without NRI Growth Rate is ranked higher than
97% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. ATEC: 119.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ATEC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -36.8  Med: -13.8 Max: 128.2
Current: 119.2
-36.8
128.2
GuruFocus has detected 2 Warning Signs with Alphatec Holdings Inc $ATEC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ATEC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ATEC Guru Trades in Q1 2016

Jim Simons 889,000 sh (+24.58%)
» More
Q2 2016

ATEC Guru Trades in Q2 2016

Jim Simons 1,045,800 sh (+17.64%)
» More
Q3 2016

ATEC Guru Trades in Q3 2016

Jim Simons 169,245 sh (+94.20%)
» More
Q4 2016

ATEC Guru Trades in Q4 2016

Jim Simons 313,545 sh (+85.26%)
» More
» Details

Insider Trades

Latest Guru Trades with ATEC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:BLFS, AMEX:DXR, AMEX:RVP, NAS:UNIS, AMEX:ISR, NAS:PDEX, OTCPK:LDSYF, NAS:CASM, NAS:BMRA, OTCBB:NEPH, OTCPK:REPR, NAS:SKLN, OTCPK:IGAP, OTCPK:STXS, OTCPK:UEEC, NAS:DXTR, NAS:AKER, OTCPK:VPTDF, AMEX:MLSS, NAS:SSKN » details
Traded in other countries:L1Z1.Germany,
Alphatec Holdings Inc is a medical technology company. It is engaged in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders.

Alphatec Holdings Inc was incorporated on March 4, 2005. The Company is a medical technology company, which is engaged in the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on products that treat conditions that affect the aging spine. The Company's product portfolio and pipeline includes a number of spinal disorder products and systems focused on solutions addressing the cervical, thoracolumbar, intervertebral, minimally invasive, vertebral compression fracture, osteoporotic bone, and spinal stenosis markets. Its main product offerings are focused on the market for orthopedic spinal disorder solution products. The Company also sells allograft spacers available in different shapes and sizes, each with corresponding instrumentation, which are intended for use in the cervical, thoracic, and lumbar regions of the spine. The Company operates an in-house manufacturing facility that enables it to deliver solutions to meet surgeons' and patients' needs. In addition to selling its products in the U.S., the Company also sells its products in Japan, the European Union and Hong Kong. It conducts its manufacturing operations at its facilities in Carlsbad, California. Its products and systems are made of titanium, titanium alloy, stainless steel and a strong, heat resistant, radiolucent, biocompatible plastic called polyetheretherketone, or PEEK. It sells its products directly to distributors, and its distributors resell its products to hospitals. The competitors of Company are Medtronic Sofamor Danek, Johnson & Johnson (DePuy/Synthes), Stryker, Biomet, NuVasive, Zimmer, Orthofix, Globus Medical, Integra Life Science, LDR Spine and others. The Company's products are subject to extensive regulation by the FDA and other U.S. federal and state regulatory bodies and comparable authorities in other countries.

Ratios

vs
industry
vs
history
PS Ratio 0.08
ATEC's PS Ratio is ranked higher than
98% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. ATEC: 0.08 )
Ranked among companies with meaningful PS Ratio only.
ATEC' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.95 Max: 2.72
Current: 0.08
0.08
2.72
Price-to-Operating-Cash-Flow 4.04
ATEC's Price-to-Operating-Cash-Flow is ranked higher than
94% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.91 vs. ATEC: 4.04 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ATEC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.24  Med: 12.67 Max: 467.5
Current: 4.04
1.24
467.5
EV-to-EBIT -2.31
ATEC's EV-to-EBIT is ranked lower than
99.99% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.63 vs. ATEC: -2.31 )
Ranked among companies with meaningful EV-to-EBIT only.
ATEC' s EV-to-EBIT Range Over the Past 10 Years
Min: -68  Med: -7.4 Max: 112.4
Current: -2.31
-68
112.4
EV-to-EBITDA -7.59
ATEC's EV-to-EBITDA is ranked higher than
98% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. ATEC: -7.59 )
Ranked among companies with meaningful EV-to-EBITDA only.
ATEC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1255.7  Med: -3.5 Max: 139.9
Current: -7.59
-1255.7
139.9
Current Ratio 1.78
ATEC's Current Ratio is ranked lower than
68% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.37 vs. ATEC: 1.78 )
Ranked among companies with meaningful Current Ratio only.
ATEC' s Current Ratio Range Over the Past 10 Years
Min: 0.75  Med: 1.88 Max: 3.39
Current: 1.78
0.75
3.39
Quick Ratio 1.13
ATEC's Quick Ratio is ranked lower than
72% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. ATEC: 1.13 )
Ranked among companies with meaningful Quick Ratio only.
ATEC' s Quick Ratio Range Over the Past 10 Years
Min: 0.4  Med: 1.13 Max: 2.53
Current: 1.13
0.4
2.53
Days Inventory 267.87
ATEC's Days Inventory is ranked lower than
81% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.59 vs. ATEC: 267.87 )
Ranked among companies with meaningful Days Inventory only.
ATEC' s Days Inventory Range Over the Past 10 Years
Min: 155.6  Med: 230.47 Max: 267.87
Current: 267.87
155.6
267.87
Days Sales Outstanding 47.47
ATEC's Days Sales Outstanding is ranked higher than
94% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. ATEC: 47.47 )
Ranked among companies with meaningful Days Sales Outstanding only.
ATEC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.47  Med: 74.37 Max: 84.6
Current: 47.47
47.47
84.6
Days Payable 59.84
ATEC's Days Payable is ranked lower than
73% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.97 vs. ATEC: 59.84 )
Ranked among companies with meaningful Days Payable only.
ATEC' s Days Payable Range Over the Past 10 Years
Min: 48.98  Med: 78.95 Max: 117.79
Current: 59.84
48.98
117.79

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.80
ATEC's 3-Year Average Share Buyback Ratio is ranked higher than
56% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. ATEC: -1.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ATEC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -69.9  Med: -23.05 Max: -0.4
Current: -1.8
-69.9
-0.4

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.10
ATEC's Price-to-Median-PS-Value is ranked higher than
97% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ATEC: 0.10 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ATEC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.09  Med: 1.01 Max: 2.64
Current: 0.1
0.09
2.64
Earnings Yield (Greenblatt) % -43.34
ATEC's Earnings Yield (Greenblatt) % is ranked lower than
73% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. ATEC: -43.34 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ATEC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -45.66  Med: 2 Max: 3.3
Current: -43.34
-45.66
3.3

More Statistics

Revenue (TTM) (Mil) $142.4
EPS (TTM) $ -3.60
Beta1.25
Short Percentage of Float2.31%
52-Week Range $1.99 - 9.65
Shares Outstanding (Mil)8.91

Analyst Estimate

Dec17
Revenue (Mil $)
EPS ($) 0.01
EPS without NRI ($) 0.01
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for ATEC

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: TDY, GDI, ATEC, PBCT, SPAR Mar 17 2012 
Alphatec Holdings Inc. Reports Operating Results (10-Q) Nov 08 2010 
Alphatec Holdings Inc. (ATEC) CEO Dirk Kuyper buys 23,000 Shares Aug 27 2010 
Alphatec Holdings Inc. Reports Operating Results (10-Q) May 10 2010 
Alphatec Holdings Inc. (ATEC) CFO Peter C Wulff buys 4,500 Shares Mar 10 2009 

More From Other Websites
Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice... Mar 24 2017
9:14 am Alphatec enters $18.9 mln private placement of common stock, Series A Convertible Preferred... Mar 23 2017
Alphatec Holdings Announces $18.9 Million Private Placement Mar 23 2017
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition Mar 16 2017
Alphatec reports 4Q loss Mar 15 2017
Alphatec reports 4Q loss Mar 15 2017
Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results Mar 15 2017
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 09 2017
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 06 2017
Alphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer Mar 06 2017
Alphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in... Feb 28 2017
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 14 2017
Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors Feb 14 2017
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 26 2017
ETFs with exposure to Alphatec Holdings, Inc. : January 20, 2017 Jan 20 2017
ETFs with exposure to Alphatec Holdings, Inc. : December 22, 2016 Dec 22 2016
Alphatec Slides on Management Changes Dec 12 2016
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 12 2016
ETFs with exposure to Alphatec Holdings, Inc. : December 6, 2016 Dec 06 2016
ALPHATEC HOLDINGS, INC. Financials Nov 17 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)